Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ARGATROBAN

ARGATROBAN

Standard Dose
250MG/250ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview ARGATROBAN is listed in Drugs@FDA under application 022359 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ARGATROBAN Form and strength INJECTABLE; INJECTION - 250MG/250ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2010-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARGATROBAN is listed in Drugs@FDA under application 022359 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ARGATROBAN Form and strength INJECTABLE; INJECTION - 250MG/250ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2010-07-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.